SARC was awarded a Sarcoma SPORE (Specialized Programs of Research Excellence) by the National Cancer Institute (NCI) in 2012. This was the first SPORE to be awarded to a nonprofit consortium of academic researchers, and only the second SPORE in sarcoma to be awarded. The SPORE program is a National Cancer Institute grant program designed to promote collaborative, interdisciplinary translational cancer research.

clinician and clip board at patient bedside


The NCI’s five year SPORE grant programs involve both basic and clinical/applied scientists and support projects that result in new and diverse approaches to the prevention, early detection, diagnosis, and treatment of human cancers. The SARC Sarcoma SPORE engaged pediatric and medical oncology and included translational projects that were coordinated across various academic institutions bringing together the brightest and best of sarcoma research.

Learn more about the NCI Translational Research Program.


A component of the SARC Sarcoma SPORE was funding for developmental research projects.

See grant recipients.

Back to top